High Macrolide Resistance in Mycoplasma genitalium Strains Causing Infection in Auckland, New Zealand
Indira Basu, Sally Roberts, James E. Bower, Gillian Henderson, Murray Reid
Abstract
Indira Basu, Sally Roberts, James E. Bower, Gillian Henderson, Murray Reid
Abstract
M ycoplasma genitalium has been implicated as a cause of acute and chronic nonchlamydial nongonococcal urethritis (NCNGU) and pelvic inflammatory disease (PID) ([1][1]). In New Zealand, as with many other countries, the preferred treatment for NCNGU is either azithromycin or doxycycline ([2][2]).
OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
M ycoplasma genitalium has been implicated as a cause of acute and chronic nonchlamydial nongonococcal urethritis (NCNGU) and pelvic inflammatory disease (PID) ([1][1]). In New Zealand, as with many other countries, the preferred treatment for NCNGU is either azithromycin or doxycycline ([2][2]).
Key concepts: Mycoplasma genitalium, Microbiology, Biology, Virology, Macrolide Antibiotics, Mycoplasma, Mollicutes, Antibiotics